{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:15:45Z","timestamp":1769793345295,"version":"3.49.0"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The differential diagnosis of an adrenal mass is critical for clinical management. We report a case that expanded the spectrum of a rare disease and present a novel diagnostic trap for both pathologists and clinicians.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Histopathological, immunohistochemical (CD68, CD163, ALK), and molecular (FISH) analyses were performed on a right adrenal tumor from an 81-year-old male.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The tumor was diagnosed as ALK-positive histiocytosis. Uniquely, it presented as a primary adrenal mass with unusual morphology. The tumor cells showed marked anaplasia and emperipolesis. Apart from classic xanthogranuloma areas, the tumor exhibited hypercellular and hypocellular zones. Neoplastic cells in the hypercellular regions displayed anaplastic features, including a high nuclear-to-cytoplasmic ratio, prominent nucleoli, and observable mitotic figures. In contrast, neoplastic cells in the hypocellular areas were cytologically bland within a myxoid stroma. Neoplastic cells were positive for macrophage markers CD68, CD163 and ALK. Fluorescence\n                      <jats:italic>in situ<\/jats:italic>\n                      hybridization (FISH) demonstrated ALK gene rearrangements. The patient was disease-free after 8 months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>To our knowledge, this is the first documentation of primary ALK-positive histiocytosis in the adrenal gland. The presence of anaplastic features poses a high risk of misdiagnosis as a sarcoma or carcinoma, potentially leading to overly aggressive therapy. Therefore, we advocate for the inclusion of this entity in the differential diagnosis of adrenal neoplasms and recommend routine ALK testing in similar challenging cases to guide precise management and avoid therapeutic errors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1765507","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:25:40Z","timestamp":1769750740000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: ALK-positive histiocytosis presenting as an adrenal mass: a diagnostic trap due to unusual morphology"],"prefix":"10.3389","volume":"16","author":[{"given":"Wenjing","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenda","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiali","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiming","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongta","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-147017","article-title":"ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy","volume":"112","author":"Chan","year":"2008","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013338","article-title":"ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition","volume":"139","author":"Kemps","year":"2022","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41379-018-0168-6","article-title":"ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion","volume":"32","author":"Chang","year":"2019","journal-title":"Mod Pathol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1366766","article-title":"Case report: Systemic presentation of ALK-positive Histiocytosis","volume":"14","author":"Wei","year":"2024","journal-title":"Front Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1159\/000508524","article-title":"ALK-positive histiocytosis with peripheral blood histiocytes: A case report","volume":"144","author":"Swain","year":"2021","journal-title":"Acta Haematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0000000000001567","article-title":"ALK-positive histiocytosis of the breast: A clinicopathologic study highlighting spindle cell histology","volume":"45","author":"Kashima","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2022.107435","article-title":"A case of ALK-positive histiocytosis with multiple lesions in the unilateral breast: A case report","volume":"97","author":"Kurita","year":"2022","journal-title":"Int J Surg Case Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/1066896920976862","article-title":"Local ALK-positive histiocytosis with unusual morphology and novel TRIM33-ALK gene fusion","volume":"29","author":"Tran","year":"2021","journal-title":"Int J Surg Pathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12105-025-01766-2","article-title":"Langerhans cell histiocytosis and other histiocytic lesions","volume":"19","author":"McKinney","year":"2025","journal-title":"Head Neck Pathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/ejh.12755","article-title":"Histiocytic sarcoma as a secondary Malignancy: pathobiology, diagnosis, and treatment","volume":"97","author":"Ansari","year":"2016","journal-title":"Eur J Haematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13801","article-title":"Histiocytic and dendritic cell sarcomas of hematopoietic origin share targetable genomic alterations distinct from follicular dendritic cell sarcoma","volume":"26","author":"Massoth","year":"2021","journal-title":"Oncologist"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-00673-x","article-title":"The mutational landscape of histiocytic sarcoma associated with lymphoid Malignancy","volume":"34","author":"Egan","year":"2021","journal-title":"Mod Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0200-x","article-title":"Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma","volume":"32","author":"Shanmugam","year":"2019","journal-title":"Mod Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1136\/jclinpath-2020-206733","article-title":"Rosai-Dorfman disease: an overview","volume":"73","author":"Bruce-Brand","year":"2020","journal-title":"J Clin Pathol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1765507\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:25:43Z","timestamp":1769750743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1765507\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":16,"alternative-id":["10.3389\/fonc.2026.1765507"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1765507","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"article-number":"1765507"}}